Search Results - "Huyghe, MiRa"

Clinical Trial of the Pan‐Caspase Inhibitor, IDN‐6556, in Human Liver Preservation Injury by Baskin‐Bey, E. S., Washburn, K., Feng, S., Oltersdorf, T., Shapiro, D., Huyghe, MiRa, Burgart, L., Garrity‐Park, M., Van Vilsteren, F. G. I., Oliver, L. K., Rosen, C. B., Gores, G. J.

“…Cold ischemia/warm reperfusion (CI/WR) injury remains a problem in liver transplantation. The aim of the current study was to assess the utility of the…”
Get full text

Tu1852 PHARMACOKINETICS AND PHARMACODYNAMICS OF OPL-002, A HIGHLY SELECTIVE S1P1R MODULATOR, IN HEALTHY ADULT VOLUNTEERS by Luo, Allison, Lester, Robert, Schwab, Robert, Ogilvie, Kathleen, Huyghe, MiRa, Mohan, Raju, Nuss, John, Sandborn, William J.

Get full text

Oral IDN‐6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C by Pockros, Paul J., Schiff, Eugene R., Shiffman, Mitchell L., McHutchison, John G., Gish, Robert G., Afdhal, Nezam H., Makhviladze, Manana, Huyghe, Mira, Hecht, David, Oltersdorf, Tilman, Shapiro, David A.

“…Increased rates of apoptosis (programmed cell death) have been demonstrated in many hepatic diseases including chronic hepatitis C. IDN‐6556 is a potent…”
Get full text